RxDoctor Payments Data

Nancy Easterling

Nurse Practitioner · Columbia, MSNPI 1568486124

Payments from drug & device makers

$768in general payments, 2019–2025

Across 47 payments — averaging $16.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$180
  • Lilly USA, LLC$104
  • Novo Nordisk$84
  • Pfizer$55
  • Abbott$49
  • Boehringer Ingelheim$48
  • plus $247 from 11 others

What the payments were for

  • Food & beverage$768100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$768 in reported general payments places this provider in the 70th percentile of 1,090 nurse practitioner providers in Mississippi.

See all nurse practitioner providers in Mississippi

Medicare billing

Part B allowed, 2024
$7,871
Medicare patients
124
Services billed
591

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanuviaSitagliptin Phosphate87$106,728
OzempicSemaglutide72$86,314
EliquisApixaban50$55,819
MounjaroTirzepatide31$38,833
JardianceEmpagliflozin23$29,338
MyrbetriqMirabegron35$25,694
RybelsusSemaglutide16$23,095
JanumetSitagliptin Phos/Metformin Hcl13$17,435
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog46$12,104
Novolog FlexpenInsulin Aspart11$4,979
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog13$4,353
SynthroidLevothyroxine Sodium70$3,050
Metoprolol Succinate322$2,744
Lantus SolostarInsulin Glargine,hum.Rec.Anlog11$2,322
Gabapentin260$1,980

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia, Janumet$19$124,163100 claims
Novo NordiskOzempic, Rybelsus$84$109,40988 claims
PfizerEliquis$55$55,81950 claims
Lilly USA, LLCMounjaro$104$38,83331 claims
Boehringer IngelheimJardiance$48$29,33823 claims
Astellas Pharma US IncMyrbetriq$25$25,69435 claims
AbbVieSynthroid$42$3,05070 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,090 nurse practitioner providers in Mississippi.

Other nurse practitioner in Columbia

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →